1. Infectious Diseases Society of America. Bad bugs, no drugs: as antibiotic discovery stagnates, a public health crisis brews. www.idsociety.org/badbugsnodrugs.html (accessed 2010 Mar 5).
2. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs;Cosgrove;Clin Infect Dis,2006
3. Ceftobiprole: a novel, broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus;Dauner;Am J Health-Syst Pharm,2010
4. Basilea Pharmaceutica. Press release: Basilea to regain full global right to ceftobiprole. www.basilea.com/chameleon//outbox//f5ff8e93c815aa5768da5f535e421f4c/345229.pdf (accessed 2010 Mar 5).
5. RN Adventures. Replidyne: fare the well faropenem. www.rnaventures.blogspot.com/2008/06/replidyne-fare-well-faropenem.html (accessed 2010 Mar 25).